TTEK insider resale notice: 2,390 common shares via Morgan Stanley

Rhea-AI Filing Summary

Tetra Tech (TTEK) Form 144 filing discloses a proposed sale of 2,390 common shares through Morgan Stanley Smith Barney with an aggregate market value of $86,050.04. The shares were originally received as performance shares on 11/23/2021. The filing lists approximately 262,773,412 shares outstanding and indicates an approximate sale date of 08/14/2025 on NASDAQ. No other securities were reported sold in the prior three months. The filer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider resale notice for a small equity block; unlikely to move valuation materially.

The Form 144 documents a proposed disposition of 2,390 common shares valued at $86,050.04, representing a negligible fraction of Tetra Tech's ~262.8 million shares outstanding. The shares were performance-based awards acquired on 11/23/2021 and are to be sold through Morgan Stanley Smith Barney. This is a standard Rule 144 notice that signals compliance with resale rules rather than a company operational development. No recent sales were reported in the prior three months, and the filer certifies absence of undisclosed material information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing insider liquidity from long-held performance shares, with no governance red flags disclosed.

The filing reflects an insider converting previously granted performance shares into cash via a brokered sale, following Rule 144 procedures. Key governance considerations—timing, amount relative to holdings, and certification about material information—are addressed by the form. There is no indication of accelerated or unusual selling activity and no reportable sales in the prior three months, which reduces immediate governance concern. All provided fields align with routine disclosure expectations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2390	86050.04	262773412	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/23/2021	Performance Shares	Issuer			2390	11/23/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TTEK Form 144 disclose?

The filing discloses a proposed sale of 2,390 common shares valued at $86,050.04, to be executed via Morgan Stanley Smith Barney around 08/14/2025.

When and how were the shares acquired for this TTEK filing?

The shares were acquired as performance shares on 11/23/2021 from the issuer; payment is listed as Not Applicable (award grant).

How large is the proposed sale relative to Tetra Tech's outstanding shares?

The sale of 2,390 shares compares to 262,773,412 shares outstanding, making it a negligible percentage of the float.

Were there any other insider sales reported in the past three months in this filing?

No. The filing indicates Nothing to Report for securities sold during the past three months.

Does the filer state any undisclosed material information about TTEK?

By signing the notice the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.